Biofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering
28 oct. 2021 21h40 HE
|
Biofrontera Inc.
WOBURN, MA. , Oct. 28, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (“Biofrontera” or the “Company”) (Nasdaq: BFRI; BFRIW), a biopharmaceutical company specializing in the commercialization of...